(VIANEWS) – Progyny (PGNY), SSR Mining (SSRM), Farmers National Banc Corp. (FMNB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Progyny (PGNY)
29.9% sales growth and 9.66% return on equity
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Progyny has a trailing twelve months EPS of $0.31.
PE Ratio
Progyny has a trailing twelve months price to earnings ratio of 107.23. Meaning, the purchaser of the share is investing $107.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.66%.
2. SSR Mining (SSRM)
20.1% sales growth and 5.15% return on equity
SSR Mining Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and operation of precious metal resource properties in Turkey and the Americas. The company explores for gold, silver, copper, lead, and zinc deposits. Its projects include the Çöpler Gold mine located in Erzincan, Turkey; the Marigold mine located in Humboldt County, Nevada, the United States; the Seabee Gold Operation located in Saskatchewan, Canada; and the Puna Operations in Jujuy, Argentina. The company was formerly known as Silver Standard Resources Inc. and changed its name to SSR Mining Inc. in August 2017. SSR Mining Inc. was incorporated in 1946 and is based in Denver, Colorado.
Earnings Per Share
As for profitability, SSR Mining has a trailing twelve months EPS of $0.89.
PE Ratio
SSR Mining has a trailing twelve months price to earnings ratio of 16.09. Meaning, the purchaser of the share is investing $16.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.15%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 76.7% and a negative 70%, respectively.
3. Farmers National Banc Corp. (FMNB)
14.8% sales growth and 15.85% return on equity
Farmers National Banc Corp., a financial holding company, operates in the banking, trust, retirement consulting, insurance, and financial management industries. It offers commercial and retail banking services, including checking, savings, and time deposit accounts; commercial, mortgage and installment, and home equity loans; home equity lines of credit, night depository, safe deposit box, money order, bank check, automated teller machine, Internet banking, travel card, E bond transaction, MasterCard and Visa credit cards, brokerage, and other services. The company also provides personal and corporate trust services in the areas of estate settlement, trust administration, and employee benefit plans; retirement services; property and casualty insurance products and services; and various insurance products through licensed representatives, as well as invests in municipal securities. It operates through 47 locations in northeastern region of Ohio and one location in southwestern Pennsylvania. The company was founded in 1887 and is based in Canfield, Ohio.
Earnings Per Share
As for profitability, Farmers National Banc Corp. has a trailing twelve months EPS of $1.79.
PE Ratio
Farmers National Banc Corp. has a trailing twelve months price to earnings ratio of 6.36. Meaning, the purchaser of the share is investing $6.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.85%.
4. CB Financial Services (CBFV)
14% sales growth and 9.25% return on equity
CB Financial Services, Inc. operates as the bank holding company for Community Bank that provides various banking products and services for individuals and businesses in southwestern Pennsylvania, West Virginia, and Ohio. The company's primary deposit products include demand deposits, NOW accounts, money market accounts, and savings accounts, as well as time deposit products. Its loan products comprise residential real estate loans, such as one- to four-family mortgage loans, home equity installment loans, and home equity lines of credit; commercial real estate loans that are secured primarily by improved properties, such as retail facilities, office buildings, and other non-residential buildings; construction loans to individuals to finance the construction of residential dwellings, as well as for the construction of commercial properties, including hotels, apartment buildings, housing developments, and owner-occupied properties used for businesses; commercial and industrial loans, and lines of credit; consumer loans consisting of indirect auto loans, secured and unsecured loans, and lines of credit; and other loans. In addition, the company conducts insurance agency activities by offering property and casualty, commercial liability, surety, and other insurance products. It operates through its main office and 13 branch offices in Greene, Allegheny, Washington, Fayette, and Westmoreland counties in southwestern Pennsylvania; Marshall and Ohio counties in West Virginia; and Belmont County in Ohio, as well as one loan production offices in Allegheny County. The company was founded in 1901 and is headquartered in Carmichaels, Pennsylvania.
Earnings Per Share
As for profitability, CB Financial Services has a trailing twelve months EPS of $2.18.
PE Ratio
CB Financial Services has a trailing twelve months price to earnings ratio of 9.75. Meaning, the purchaser of the share is investing $9.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.25%.
5. Toro Company (TTC)
7.7% sales growth and 37.5% return on equity
The Toro Company provides innovative solutions for the outdoor environment worldwide. It operates through two segments Professional and Residential. The company's Professional segment offers turf and landscape equipment products, including sports fields and grounds mowing and maintenance equipment, golf course mowing and maintenance equipment, landscape contractor mowing equipment, landscape creation and renovation equipment, and other maintenance equipment; rental, specialty, and underground construction equipment, such as horizontal directional drills, walk and ride trenchers, stand-on skid steers, vacuum excavators, stump grinders, turf renovation products, asset locators, pipe rehabilitation solutions, materials handling equipment, and other after-market tools; and snow and ice management equipment, including snowplows; as well as stand-on snow and ice removal equipment, such as the related snowplow, snow brush, and snow thrower attachments, salt and sand spreaders, and related parts and accessories for light and medium duty trucks, utility task vehicles, skid steers, and front-end loaders. It also provides irrigation and lighting products that consist of sprinkler heads, electric and hydraulic valves, controllers, computer irrigation central control systems, coupling systems, and ag-irrigation drip tape and hose products, as well as professionally installed landscape lighting products offered through distributors and landscape contractors. Its Residential segment provides walk power mowers, zero-turn riding mowers, snow throwers, replacement parts, and home solution products that include grass and hedge trimmers, leaf blowers, blower-vacuums, chainsaws, string trimmers, hoses, and hose-end retail irrigation products. The company sells its products through a network of distributors, dealers, mass retailers, hardware retailers, equipment rental centers, home centers, and online. The Toro Company was founded in 1914 and is headquartered in Bloomington, Minnesota.
Earnings Per Share
As for profitability, Toro Company has a trailing twelve months EPS of $4.55.
PE Ratio
Toro Company has a trailing twelve months price to earnings ratio of 23.28. Meaning, the purchaser of the share is investing $23.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.5%.
Volume
Today’s last reported volume for Toro Company is 210847 which is 65.6% below its average volume of 612996.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 4.73B for the twelve trailing months.
6. Exelixis (EXEL)
7.1% sales growth and 7.76% return on equity
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.
Earnings Per Share
As for profitability, Exelixis has a trailing twelve months EPS of $0.54.
PE Ratio
Exelixis has a trailing twelve months price to earnings ratio of 35.02. Meaning, the purchaser of the share is investing $35.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.76%.
Sales Growth
Exelixis’s sales growth is 19.2% for the ongoing quarter and 7.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6%, now sitting on 1.61B for the twelve trailing months.
Yearly Top and Bottom Value
Exelixis’s stock is valued at $18.91 at 20:23 EST, way below its 52-week high of $23.26 and way higher than its 52-week low of $14.87.
Volume
Today’s last reported volume for Exelixis is 1415200 which is 55.46% below its average volume of 3177870.
7. Bank of America (BAC)
6.5% sales growth and 10.47% return on equity
Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. Its Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, noninterest-and interest-bearing checking accounts, and investment accounts and products; and credit and debit cards, residential mortgages, and home equity loans, as well as direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The company's Global Wealth & Investment Management segment offers investment management, brokerage, banking, and trust and retirement products and services; and wealth management solutions, as well as customized solutions, including specialty asset management services. Its Global Banking segment provides lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, and short-term investing options and merchant services; working capital management solutions; and debt and equity underwriting and distribution, and merger-related and other advisory services. The company's Global Markets segment offers market-making, financing, securities clearing, settlement, and custody services, as well as risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. The company was founded in 1784 and is based in Charlotte, North Carolina.
Earnings Per Share
As for profitability, Bank of America has a trailing twelve months EPS of $3.33.
PE Ratio
Bank of America has a trailing twelve months price to earnings ratio of 8.35. Meaning, the purchaser of the share is investing $8.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.47%.
Volume
Today’s last reported volume for Bank of America is 34204500 which is 44.6% below its average volume of 61745500.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 17.8% and 2.5%, respectively.
Moving Average
Bank of America’s worth is under its 50-day moving average of $30.25 and way under its 200-day moving average of $33.28.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 31, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 3.01%.
Previous days news about Bank of America(BAC)
- According to Zacks on Thursday, 4 May, "Similar to Morgan Stanley, Wall Street firms, including Bank of America and Citigroup Inc., have been reducing workforce in their IB and wealth management divisions.", "Likewise, in February, it was reported that Bank of America was planning to cut jobs in its investment bank. "
- According to Zacks on Thursday, 4 May, "Most of the fund’s exposure is in companies like Chevron (2.88%), Bank of America (2.87%) and Elevance Health (2.83%) as of 10/31/2022."
- According to CNBC on Saturday, 6 May, "More recently, he injected $5 billion into Goldman Sachs in 2008 and another $5 billion in Bank of America in 2011, helping stabilize both of those firms."
